Last September, I have written why I buy RMG at a high valuation of 37x PE. You can read about it here. The group has just announced its results this morning and it is within my expectation.
Revenue has grown 15% but net profit grew by 1.3% only. As mentioned earlier, I expected its earning to be lumpy for the next 2 years due to its expansion. Staff cost which takes up about 50% of the revenue has increased by 19%. Having said that it is heartening its operation cash flow has increased by 8%.
I took a look at its performance in 2001 when Raffles Hospital opened. That year, they made a loss. The loss was reversed the subsequent year and from 2002 to 2012, RMG earning grew at CAGR of 29%. With a much stronger balance sheet now, I doubt they would go into a loss but a dip in net profit in 2017/2018 is definitely possible. However, from 2019 onwards, I expect a good growth in its earning.
So why not sell now and purchase only in 2018 or 2019? I guess I am afraid that management proves me wrong and do even better than my expectation and earning continues to grow from 2017 and I would not be able to participate in its growth for the next decade.
I will continue to hold on to my current stake but will not add on in the short term.

Discover more from The Fat Investor

Subscribe to get the latest posts sent to your email.